Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists.
- DOI
- 10.1111/bjh.70435
- Published
- 2026 May
- Container
- British journal of haematology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bjh.70435,
title = {Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists.},
author = {Banerjee R and Dong S and McCaughan G and Mehra N and Wang B and Sperling AS and Cowan AJ and Anderson LD Jr and Rajkumar SV and Kaur G},
year = {2026},
journal = {British journal of haematology},
doi = {10.1111/bjh.70435},
url = {https://doi.org/10.1111/bjh.70435}
}RIS
TY - JOUR TI - Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists. AU - Banerjee R AU - Dong S AU - McCaughan G AU - Mehra N AU - Wang B AU - Sperling AS AU - Cowan AJ AU - Anderson LD Jr AU - Rajkumar SV AU - Kaur G PY - 2026 JO - British journal of haematology DO - 10.1111/bjh.70435 UR - https://doi.org/10.1111/bjh.70435 ER -
APA
R, B., S, D., G, M., N, M., B, W., AS, S., AJ, C., Jr, A. L., SV, R., & G, K. (2026). Preferred standard-of-care carfilzomib dosing in multiple myeloma: An international survey of haematologists/oncologists.. British journal of haematology. https://doi.org/10.1111/bjh.70435
Source records
- pubmed · retrieved 2026-09-27T00:59:59.379Z